PCM
Peregrine Capital Management’s Collegium Pharmaceutical COLL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-344,532
| Closed | -$10.6M | – | 324 |
|
|
2023
Q4 | $10.6M | Sell |
344,532
-114,658
| -25% | -$3.53M | 0.32% | 64 |
|
|
2023
Q3 | $10.3M | Sell |
459,190
-19,636
| -4% | -$439K | 0.31% | 92 |
|
|
2023
Q2 | $10.3M | Sell |
478,826
-19,822
| -4% | -$426K | 0.28% | 118 |
|
|
2023
Q1 | $12M | Sell |
498,648
-42,744
| -8% | -$1.03M | 0.35% | 81 |
|
|
2022
Q4 | $12.6M | Sell |
541,392
-5,889
| -1% | -$137K | 0.39% | 65 |
|
|
2022
Q3 | $8.77M | Sell |
547,281
-1,477
| -0.3% | -$23.7K | 0.28% | 158 |
|
|
2022
Q2 | $9.72M | Sell |
548,758
-7,900
| -1% | -$140K | 0.29% | 143 |
|
|
2022
Q1 | $11.3M | Sell |
556,658
-19,241
| -3% | -$392K | 0.27% | 146 |
|
|
2021
Q4 | $10.8M | Sell |
575,899
-106,165
| -16% | -$1.98M | 0.22% | 182 |
|
|
2021
Q3 | $13.5M | Buy |
+682,064
| New | +$13.5M | 0.28% | 130 |
|